Limit Emergence Phenomena After General Anesthesia

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ambu
AmbuDenmark - Ballerup
1 program
Induction of anesthesiaN/A1 trial
Active Trials
NCT02708836RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AmbuInduction of anesthesia

Clinical Trials (1)

NCT02708836AmbuInduction of anesthesia

Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique

Start: Jan 2020Est. completion: Jun 2026
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space